SCHEMBL14021407

SCHEMBL14021407

CCNC(=O)N1CCN(C(=O)c2ccc(Nc3nccc(-c4ccc(Cl)cc4)n3)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 8/20 0.51
▸ JAK3 P52333 7/20 0.51
▸ IKBKB O14920 5/20 0.51
▸ CHUK O15111 4/20 0.51
▸ PIK3CA P42336 2/20 0.50
▸ PIK3CB P42338 2/20 0.50
▸ PIK3CG P48736 2/20 0.50
▸ CDK2 P24941 2/20 0.49
▸ CDK1 P06493 1/20 0.49
▸ CAMK2D Q13557 4/20 0.48
▸ JAK1 P23458 2/20 0.48
▸ TYK2 P29597 2/20 0.48
▸ HDAC1 Q13547 2/20 0.48
▸ BMPR1B O00238 1/20 0.48
▸ PLK4 O00444 1/20 0.48
▸ CIT O14578 1/20 0.48
▸ GAK O14976 1/20 0.48
▸ OPA1 O60313 1/20 0.48
▸ ROCK2 O75116 1/20 0.48
▸ STK16 O75716 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8312575 0.93 JAK2 (0.49) JAK2JAK3IKBKBCHUKPIK3CA
SCHEMBL4063691 0.89 JAK2 (0.52) JAK2JAK3IKBKBCHUKPIK3CA
SCHEMBL8311614 0.89 PIK3CA (0.47) JAK2JAK3IKBKBCHUKPIK3CA
SCHEMBL8311018 0.89 JAK2 (0.61) JAK2JAK3IKBKBCHUKPIK3CA
SCHEMBL14021080 0.89 PIK3CA (0.52) JAK2JAK3IKBKBCHUKPIK3CA
SCHEMBL8312432 0.88 PIK3CA (0.47) JAK2JAK3IKBKBCHUKPIK3CA
SCHEMBL14021629 0.88 JAK2 (0.54) JAK2JAK3IKBKBCHUKPIK3CA
SCHEMBL8312148 0.87 CDK1 (0.62) JAK2JAK3IKBKBCHUKPIK3CA
SCHEMBL1512786 0.87 PIK3CA (0.55) JAK2JAK3IKBKBCHUKPIK3CA
SCHEMBL14021410 0.87 PIK3CA (0.46) JAK2JAK3IKBKBCHUKPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 — — US disclosed
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 — — US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
Send feedback